TRIVASTAL RETARD

TRIVASTAL RETARD contains the active ingredient Piribedil. It is a medication primarily used in the treatment of Parkinson’s disease and certain other neurological disorders. Piribedil acts as a dopamine receptor agonist, mimicking the effects of dopamine in the brain.

Uses: TRIVASTAL RETARD is prescribed for managing symptoms associated with Parkinson’s disease, such as tremors, stiffness, slowness of movement, and postural instability. It may also be used to treat some symptoms of vascular dementia and other cognitive impairments.

Mechanism of Action: Piribedil exerts its therapeutic effects by stimulating dopamine receptors, particularly the D2 and D3 subtypes, in the brain’s basal ganglia. This leads to enhanced dopaminergic neurotransmission, which helps alleviate motor symptoms and improve motor function in Parkinson’s disease.

Dosage and Administration: The dosage of TRIVASTAL RETARD varies depending on the individual’s condition, response to treatment, and other factors. It is typically administered orally as a prolonged-release tablet, usually once or twice daily. The dosage should be adjusted carefully by a healthcare professional based on the patient’s needs and tolerance.

Precautions:

• TRIVASTAL RETARD should be used with caution in patients with a history of cardiovascular disease, as it may cause low blood pressure or other cardiovascular effects.
• It may interact with certain medications, including other dopamine agonists, antipsychotics, and medications affecting the QT interval on the electrocardiogram (ECG). Therefore, it is essential to inform the healthcare provider about all medications being taken.
• Patients should be monitored for potential adverse effects, including dizziness, hallucinations, low blood pressure, and abnormal involuntary movements.

Side Effects: Common side effects of TRIVASTAL RETARD may include nausea, dizziness, headache, fatigue, hallucinations, and gastrointestinal disturbances. Less commonly, it may cause low blood pressure, abnormal involuntary movements, and psychiatric symptoms such as confusion or agitation.

In Summary: TRIVASTAL RETARD containing Piribedil is a dopamine agonist medication used for the symptomatic treatment of Parkinson’s disease and certain cognitive impairments. By stimulating dopamine receptors in the brain, it helps alleviate motor symptoms and improve motor function in affected individuals